title: Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma.
abstract: Cytogenetic abnormalities of chromosome 9 (9p21) have been reported in a large number of tumors that include malignant melanomas, gliomas, lung cancers and leukemias. These aberrations on 9p have been previously shown to involve the loss of the interferon gene cluster and the gene for methylthioadenosine phosphorylase (MTAP), both of which have been mapped to the 9p21 region. Recently, two putative tumor suppressor gene(s) CDKN2 and MTS2, have been mapped to the 9p21 region, and have been shown to be deleted in a large number of hematopoietic and solid malignancies. In this study we report a cytogenetic and a detailed molecular analysis of a myxoid chondrosarcoma cell line 105KC and its clonal derivatives 105AJ, 105AJ1.1, 105AJ3.1, and 105AJ5.1. Specifically, we have demonstrated chromosome 9p21 related abnormalities by cytogenetic analysis, the associated loss of the interferon gene cluster, and the loss of the immunoreactive MTAP protein and activity. In addition, we have also shown the presence of deletions involving the CDKN2 and the MTS2 putative tumor suppressor genes in these chondrosarcoma cell lines. The above studies were extended to other chondrosarcoma cell lines and primary tumors, where similar deletions of the CDKN2 and MTS2 genes were found to be present (unpublished data). This suggests a potential role for the involvement of the CDKN2 and MTS2 putative tumor suppressor genes in the development of chondrosarcomas.
authors.affiliation: Department of Medicine, Loyola University Medical Center, Maywood, IL 60153, USA.
authors.forename: A A
authors.initials: AA
authors.lastname: Jagasia
authors.forename: J A
authors.initials: JA
authors.lastname: Block
authors.forename: M O
authors.initials: MO
authors.lastname: Diaz
authors.forename: T
authors.initials: T
authors.lastname: Nobori
authors.forename: S
authors.initials: S
authors.lastname: Gitelis
authors.forename: S E
authors.initials: SE
authors.lastname: Inerot
authors.forename: A P
authors.initials: AP
authors.lastname: Iyer
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000235:genetics*; D002352:Carrier Proteins / Q000235:genetics*; D002813:Chondrosarcoma / Q000235:genetics*; D002871:Chromosome Banding; D002899:Chromosomes, Human, Pair 9; D019941:Cyclin-Dependent Kinase Inhibitor p16; D017931:DNA Primers / Q000737:chemistry; D004273:DNA, Neoplasm / Q000235:genetics; D010450:Endopeptidases / Q000235:genetics*; D016147:Genes, Tumor Suppressor; D006801:Humans; D008297:Male; D011003:Ploidies; D011683:Purine-Nucleoside Phosphorylase / Q000378:metabolism; D029702:Schizosaccharomyces pombe Proteins; D017384:Sequence Deletion; D014407:Tumor Cells, Cultured
chemical_list: D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D017931:DNA Primers; D004273:DNA, Neoplasm; D029702:Schizosaccharomyces pombe Proteins; D011683:Purine-Nucleoside Phosphorylase; C021784:5'-methylthioadenosine phosphorylase; D010450:Endopeptidases; C084436:rpt2 protein, S pombe